Page last updated: 2024-09-02

tamibarotene and Leukemia, Prolymphocytic

tamibarotene has been researched along with Leukemia, Prolymphocytic in 1 studies

*Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, Y; Kagechika, H; Kawachi, E; Shudo, K; Yamakawa, T1

Other Studies

1 other study(ies) available for tamibarotene and Leukemia, Prolymphocytic

ArticleYear
Retinobenzoic acids. 5. Retinoidal activities of compounds having a trimethylsilyl or trimethylgermyl group(s) in human promyelocytic leukemia cells HL-60.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:5

    Topics: Antineoplastic Agents; Benzoates; Cell Differentiation; Chemical Phenomena; Chemistry; Humans; Leukemia, Prolymphocytic; Organometallic Compounds; Silicon; Structure-Activity Relationship; Trimethylsilyl Compounds; Tumor Cells, Cultured

1990